0001209191-21-013772.txt : 20210224
0001209191-21-013772.hdr.sgml : 20210224
20210224161752
ACCESSION NUMBER: 0001209191-21-013772
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210222
FILED AS OF DATE: 20210224
DATE AS OF CHANGE: 20210224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shetzline Michael
CENTRAL INDEX KEY: 0001808509
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 21673387
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-22
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001808509
Shetzline Michael
C/O IRONWOOD PHARMACEUTICALS, INC.
100 SUMMER STREET, SUITE 2300
BOSTON
MA
02110
0
1
0
0
CMO, SVP & Head of Drug Devt.
Class A Common Stock
2021-02-22
4
A
0
58252
0.00
A
165298
D
The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
/s/ Conor Kilroy, Attorney-in-Fact
2021-02-24